Kissei Pharmaceutical Co., Ltd. Obtains Manufacturing Approval For URIEF Capsule, Benign Prosatic Hypertrophy Drug

Published: Jan 24, 2006

Tokyo (JCN) Jan 24, 2006 - Kissei Pharmaceutical announced on January 23 that it has received approval from the Ministry of Health, Labor and Welfare to manufacture URIEF Capsule 2mg/4mg, its proprietary agent for treating benign prostatic hypertrophy (BPH).

Back to news